Novo's False Ad Suit Against Eli Lilly Ramps Up GLP-1 Rivalry
Pharmaceutical giant Novo Nordisk Inc. slapped rival Eli Lilly & Co. with a false advertising suit in New Jersey federal court Tuesday, calling a marketing campaign for the rival's weight loss...To view the full article, register now.
Already a subscriber? Click here to view full article